Women who enter menopause before the age of 40 are more likely to die young, but may lower their risk with hormone therapy, according to research presented at the 26th European Congress of Endocrinology in Stockholm.
Sandoz wins FDA approval for first two biosimilars for Amgen’s blockbuster bone drug
Sandoz said Tuesday that the FDA signed off on two of its biosimilars to Amgen’s bone drug denosumab. But as with other high-profile biosimilar approvals,
March 6, 2024